No blogging for me. I’m sick as a dog (summer colds suck), and have to put together the annual Top Companies report (top 20 pharma, top 10 biopharma) for my magazine.
Now if you’ll excuse me, I have to explain why last year’s optimism about Merck was misguided . . .
